Welcome to Roger’s CaringBridge Site
Sign In to Show Your SupportDrugs that target these checkpoints (called checkpoint inhibitors) can be used to treat some people with non-small cell lung cancer (NSCLC). Cancer.org
Dad will be receiving durvalumab (generic name - imfinzin) every two weeks for the next year. It will be administered through an IV at the cancer center right in Robbinsdale. He still has a port in his chest, so it is a pretty low key appointment for him. He may administer fatigue, but it won't be anything as severe as the radiation / chemo side effects.
More on durvalumab here and here.
1 Heart • 1 Comment